FENC
Fennec Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.39
−1.27%Aug 11, 2026, 15:07 UTC
Adherex Technologies, operating as Fennec Pharmaceuticals, reported second-quarter 2026 net product sales of $17.1 million, up approximately 78% from $9.7 million in the prior-year period.